What is the current stock price of Alpha Cognition Inc. (ACOGF)?

As of the latest market data, Alpha Cognition Inc. (ACOGF) is trading at $5.72. The stock has seen a loss of 0.00% today.

Does Alpha Cognition Inc. (ACOGF) pay a dividend?

Based on current data, Alpha Cognition Inc. does not have a confirmed active dividend policy.

What is the market cap of Alpha Cognition Inc.?

The current market capitalization of Alpha Cognition Inc. (ACOGF) is approximately unavailable.

ACOGF

Alpha Cognition Inc.·Healthcare

5.73

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $5.7252W H: $5.72

ACOGF NEWS

businesswire.com

Mar 26

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. “2025 was a year of strong commercial execution for Alpha Cognition as we continued to build momentum for ZUNVEYL – the f.

Company Profile

Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; and ALPHA-0602, a gene therapy for the treatment of ALS. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Sector

Healthcare

Industry

Biotechnology

IPO Date

2021-06-28

Beta

3.29

Websitewww.alphacognition.com↗